Roessingh Research and Development, Enschede, The Netherlands.
Department of Biomechanical Engineering, University of Twente, Enschede, The Netherlands.
J Neuroeng Rehabil. 2021 Nov 8;18(1):162. doi: 10.1186/s12984-021-00951-y.
Technology-supported rehabilitation can help alleviate the increasing need for cost-effective rehabilitation of neurological conditions, but use in clinical practice remains limited. Agreement on a core set of reliable, valid and accessible outcome measures to assess rehabilitation outcomes is needed to generate strong evidence about effectiveness of rehabilitation approaches, including technologies. This paper collates and synthesizes a core set from multiple sources; combining existing evidence, clinical practice guidelines and expert consensus into European recommendations for Clinical Assessment of Upper Limb In Neurorehabilitation (CAULIN).
Data from systematic reviews, clinical practice guidelines and expert consensus (Delphi methodology) were systematically extracted and synthesized using strength of evidence rating criteria, in addition to recommendations on assessment procedures. Three sets were defined: a core set: strong evidence for validity, reliability, responsiveness and clinical utility AND recommended by at least two sources; an extended set: strong evidence OR recommended by at least two sources and a supplementary set: some evidence OR recommended by at least one of the sources.
In total, 12 measures (with primary focus on stroke) were included, encompassing body function and activity level of the International Classification of Functioning and Health. The core set recommended for clinical practice and research: Fugl-Meyer Assessment of Upper Extremity (FMA-UE) and Action Research Arm Test (ARAT); the extended set recommended for clinical practice and/or clinical research: kinematic measures, Box and Block Test (BBT), Chedoke Arm Hand Activity Inventory (CAHAI), Wolf Motor Function Test (WMFT), Nine Hole Peg Test (NHPT) and ABILHAND; the supplementary set recommended for research or specific occasions: Motricity Index (MI); Chedoke-McMaster Stroke Assessment (CMSA), Stroke Rehabilitation Assessment Movement (STREAM), Frenchay Arm Test (FAT), Motor Assessment Scale (MAS) and body-worn movement sensors. Assessments should be conducted at pre-defined regular intervals by trained personnel. Global measures should be applied within 24 h of hospital admission and upper limb specific measures within 1 week.
The CAULIN recommendations for outcome measures and assessment procedures provide a clear, simple, evidence-based three-level structure for upper limb assessment in neurological rehabilitation. Widespread adoption and sustained use will improve quality of clinical practice and facilitate meta-analysis, critical for the advancement of technology-supported neurorehabilitation.
技术支持的康复可以帮助缓解对经济有效的神经疾病康复的需求不断增加,但在临床实践中的应用仍然有限。需要就一组可靠、有效和可及的核心结果测量指标达成一致,以评估康复效果,从而为包括技术在内的康复方法的有效性提供有力证据。本文从多个来源中整理并综合了一组核心指标;将现有证据、临床实践指南和专家共识(德尔菲方法)结合起来,为欧洲神经康复上肢临床评估(CAULIN)提出建议。
使用证据强度评估标准系统地提取和综合了来自系统评价、临床实践指南和专家共识(德尔菲方法)的数据,此外还提出了评估程序的建议。定义了三组:核心组:有效性、可靠性、反应性和临床实用性的强证据,并且至少有两个来源推荐;扩展组:强证据或至少有两个来源推荐;补充组:一些证据或至少有一个来源推荐。
共有 12 项措施(主要关注中风)被纳入,涵盖了国际功能、残疾和健康分类的身体功能和活动水平。核心组建议用于临床实践和研究:上肢 Fugl-Meyer 评估(FMA-UE)和动作研究上肢测试(ARAT);扩展组建议用于临床实践和/或临床研究:运动学测量、方块和木块测试(BBT)、Chedoke 上肢活动量评估(CAHAI)、Wolf 运动功能测试(WMFT)、九孔插板测试(NHPT)和 ABILHAND;补充组建议用于研究或特定场合:运动指数(MI);Chedoke-McMaster 中风评估(CMSA)、中风康复评估运动(STREAM)、Frenchay 上肢测试(FAT)、运动评估量表(MAS)和穿戴式运动传感器。评估应由经过培训的人员在预先规定的时间间隔内进行。全面评估应在入院后 24 小时内进行,上肢特定评估应在 1 周内进行。
CAULIN 对结果测量指标和评估程序的建议为神经康复上肢评估提供了一个清晰、简单、基于证据的三级结构。广泛采用和持续使用将提高临床实践的质量,并促进荟萃分析,这对于推进技术支持的神经康复至关重要。